Evidence for mitochondrial UPR gene activation in familial and sporadic alzheimer’s disease

Current Alzheimer Research

Volumn 13, Issue 6, 2016, Pages 610-614

  Beck, John S ^a   Mufson, Elliott J ^c   Counts, Scott E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b St Mary's Mercy Medical Center   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Alzheimer; Mitochondria; Mitophagy; Presenilin; Unfolded protein response

Indexed keywords

CHAPERONE; CHAPERONIN 60; DNAJA3 PROTEIN; EARLY PREGNANCY FACTOR; ENDOPEPTIDASE CLP; OXIDOREDUCTASE; PRESENILIN 1; PROTEASE YME1L1; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; HOMEOSTASIS; HUMAN; HUMAN TISSUE; MITOCHONDRION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; WESTERN BLOTTING; FAMILY; FRONTAL LOBE; GENETICS; MENTAL HEALTH; METABOLISM; MIDDLE AGED; MITOCHONDRIAL GENE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOTTING, WESTERN; FAMILY; FRONTAL LOBE; GENES, MITOCHONDRIAL; HUMANS; MENTAL STATUS SCHEDULE; MIDDLE AGED; MITOCHONDRIA; POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION; UNFOLDED PROTEIN RESPONSE;

EID: 84966378255     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666151221145445     Document Type: Article

References (30)

1. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017-23 (2001).
2. Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, et al. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J Alzheimers Dis 9: 147-53 (2006).
3. Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497: 451-7 (2013).
4. Burte F, Carelli V, Chinnery PF, Yu-Wai-Man P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol 11: 11-24 (2015).
5. Aldridge JE, Horibe T, Hoogenraad NJ. Discovery of genes activated by the mitochondrial unfolded protein response (mtUPR) and cognate promoter elements. PLoS One 2: e874 (2007).
6. Haynes CM, Fiorese CJ, Lin YF. Evaluating and responding to mitochondrial dysfunction: the mitochondrial unfolded-protein response and beyond. Trends Cell Biol 23: 311-8 (2013).
7. Zhao Q, Wang J, Levichkin IV, Stasinopoulos S, Ryan MT, Hoogenraad NJ. A mitochondrial specific stress response in mammalian cells. EMBO J 21: 4411-9 (2002).
8. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304: 448-52 (2004).
9. Schon EA, Area-Gomez E. Is Alzheimer's disease a disorder of mitochondria-associated membranes? J Alzheimers Dis 20(2): S281-92 (2010).
10. Schuessel K, Frey C, Jourdan C, Keil U, Weber CC, Muller-Spahn F, et al. Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. Free Radic Biol Med 40: 850-62 (2006).
11. Alldred MJ, Che S, Ginsberg SD. Terminal continuation (TC) RNA amplification without second strand synthesis. J Neurosci Methods 177: 381-5 (2009).
12. Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, et al. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol 64: 1771-6 (2007).
13. Ginsberg SD. Transcriptional profiling of small samples in the central nervous system. Methods Mol Biol 439: 147-58 (2008).
14. Weinberg RB, Mufson EJ, Counts SE. Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment. Front Neurosci 9: 430 (2015).
15. Osorio C, Sullivan PM, He DN, Mace BE, Ervin JF, Strittmatter WJ, et al. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice. Neurobiol Aging 28: 1853-62 (2007).
16. Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol 65: 592-601 (2006).
17. Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 56: 520-31 (2004).
18. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Scheper W. Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease. Neurodegener Dis 10: 212-5 (2012).
19. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101: 2173-8 (2004).
20. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor downregulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70: 462-73 (2002).
21. Counts SE, Alldred MJ, Che S, Ginsberg SD, Mufson EJ. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology 79C: 172-9 (2013).
22. Mufson EJ, Counts SE, Che S, Ginsberg SD. Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Prog Brain Res 158: 197-222 (2006).
23. Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, et al. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry 68: 885-93 (2010).
24. Pellegrino MW, Nargund AM, Haynes CM. Signaling the mitochondrial unfolded protein response. Biochim Biophys Acta 1833: 410-6 (2013).
25. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, et al. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3: 614-5 (2007).
26. Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, et al. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J Alzheimers Dis 20 (Suppl. 2): S401-S412 (2010).
27. Cardoso SM, Pereira CF, Moreira PI, Arduino DM, Esteves AR, Oliveira CR. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease. Exp Neurol 223: 294-8 (2010).
28. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14: 671-80. (1995).
29. Nixon RA, Cataldo AM. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J Alzheimers Dis 9: 277-89 (2006).
30. Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res 27: 1035-48 (2002).